ML-327

ML-327 Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com

ML-327 manufacturers

  • ML327
  • ML327 pictures
  • $42.00
  • 2026-07-27
  • CAS:1883510-31-3
  • Purity: 99.48%
  • Supply Ability: 10g
ML-327 Basic information
Product Name:ML-327
Synonyms:ML-327;ML327;ML-327;ML 327;-327;3-Pyridinecarboxamide, 1,2-dihydro-2-oxo-N-[3-[[(5-phenyl-3-isoxazolyl)carbonyl]amino]propyl]-;N-(3-(2-Oxo-1,2-dihydropyridine-3-carboxamido)propyl)-5-phenylisoxazole-3-carboxamide;ML-327,Autophagy,Myc,Inhibitor,ML 327,ML327,inhibit,c-Myc;ML327, 10 mM in DMSO;Abmole M9309-2mg ML327 1883510-31-3
CAS:1883510-31-3
MF:C19H18N4O4
MW:366.37
EINECS:
Product Categories:
Mol File:1883510-31-3.mol
ML-327 Structure
ML-327 Chemical Properties
storage temp. Store at -20°C
solubility DMSO : 32 mg/mL (87.34 mM)
form Solid
color White to off-white
InChIKeyNNNDNXLMQAPQQQ-UHFFFAOYSA-N
SMILES[nH]1[c](c(ccc1)C(=O)NCCCNC(=O)c2n[o]c(c2)c3ccccc3)=O
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
ML-327 Usage And Synthesis
UsesML327 is a blocker of MYC which can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).
Biological ActivityML327 is a regulator of E-cadherin transcription th at restores E-cadherin expression in cancer cell lines and partially reverses Epithelial-to-Mesenchymal Transition (EMT). It is a potent inducer of mesenchymal-to-epithelial transition (MET) in epithelial cancers. Apparently ML327 blocks MYC expression in neuroblastomas. It induces apoptosis in cancer cells and sensitizes Ewing sarcoma cells to TRAIL.
in vivo

ML327 treatment significantly reduces tumor volume by three-fold over the two-week treatment period (p=0.02). Tumor explant weights are approximately three-fold smaller in the ML327-treated mice (p=0.01). Mice treated with ML327 lost 12% more body weight than vehicle treated mice. ML327 treatment results in a two-fold decrease in MYCN expression, confirming that ML327 inhibits xenograft MYCN expression (p=0.0035)[1].

ML-327 Preparation Products And Raw materials
Tag:ML-327(1883510-31-3) Related Product Information
Decyltrimethylammonium chloride Nodinitib-1 9H-Purine-2-carbonitrile, 6-[(3,5-difluorophenyl)aMino]-9-ethyl- ML418 [4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone ML213 N-(3,4-difluorophenyl)-2-pyridin-4-ylquinazolin-4-amine PTP1B-IN-2 ML264 ML216 ML385 ML365 ML 141 ML355 M348 ml390 (2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide 5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one